Paladin Labs News and Activities

Paladin Labs is owned by Knight Therapeutics. Knight Therapeutics has a direct presence in 2 countries.

They are in:

• Biotechnology50%
• Pharmaceuticals50%

Acquisition, funding and merger involving Knight Therapeutics.

• Knight Therapeutics has announced the acquisition of Paladin Labs  (posted on March 12 2025).

View the org chart displaying its 3 main executives

Most searched biographies at Paladin Labs

• Livio Di Francesco, Vice President and General Manager
• Isabelle Trempe, Vice President, Business Development
• Daniel Vas, Executive Director, Finance

Popular executive movements at Knight Therapeutics

• Christine Poulin, General Manager, North America, has left the company  (posted on January 14 2026).

Create your alert
to follow the executive moves at Paladin Labs.

Knight Therapeutics has 1,914 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Zymeworks has announced the acquisition of Theravance Biopharma  (posted on June 29 2026).
• Aurobindo has announced the acquisition of Lannett  (posted on June 26 2026).
• Merck has announced the acquisition of Bio-Techne  (posted on June 25 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Paladin Labs

Social media about Paladin Labs

• Paladin Labs on Wikipedia, Google News & Yahoo Finance
• Paladin Labs on LinkedIn, X (Twitter) & YouTube